Recruiting Idiopathic Thrombocytopenic Purpura Studies in Philadelphia
About Idiopathic Thrombocytopenic Purpura Clinical Trials in Philadelphia
Immune thrombocytopenia (ITP) is an autoimmune condition where the immune system destroys platelets, leading to easy bruising and bleeding. It can occur in children (often self-limiting) or adults (often chronic). Treatment includes corticosteroids, thrombopoietin receptor agonists, and rituximab.
There are currently 1 idiopathic thrombocytopenic purpura clinical trials recruiting participants in Philadelphia, PENNSYLVANIA. These studies are seeking a combined 171 participants. Research is being sponsored by Takeda. Clinical trial participation is free and participants receive study-related medical care at no cost.
Idiopathic Thrombocytopenic Purpura Clinical Trials in Philadelphia — FAQ
Are there idiopathic thrombocytopenic purpura clinical trials in Philadelphia?
Yes, there are 1 idiopathic thrombocytopenic purpura clinical trials currently recruiting in Philadelphia, PENNSYLVANIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Philadelphia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.
Are clinical trials in Philadelphia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.
What idiopathic thrombocytopenic purpura treatments are being tested?
The 1 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for idiopathic thrombocytopenic purpura.
Data updated March 2, 2026 from ClinicalTrials.gov